Back
ProShares UltraShort Nasdaq Biotech Vs. ProShares UltraShort MidCap400 Industry Stock Comparison
Sell
28
BIS
ProShares UltraShort Nasdaq Biotech
Last Price:
14.59
Seasonality Move:
-12.88%
Sell
19
MZZ
ProShares UltraShort MidCap400
Last Price:
9.43
Seasonality Move:
-12.6%
Sell
28
ProShares UltraShort Nasdaq Biotech (BIS)
is a Sell
Is ProShares UltraShort Nasdaq Biotech a Buy, Sell or Hold?
- The current ProShares UltraShort Nasdaq Biotech [BIS] share price is $14.89. The Score for BIS is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- BIS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
ProShares UltraShort MidCap400 (MZZ)
is a Sell
Is ProShares UltraShort MidCap400 a Buy, Sell or Hold?
- The current ProShares UltraShort MidCap400 [MZZ] share price is $9.62. The Score for MZZ is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- MZZ is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
BIS Stock Price Chart
What is ProShares UltraShort Nasdaq Biotech's stock price today?
-
The ProShares UltraShort Nasdaq Biotech share price today is $14.89
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIS is experiencing slight buying pressure.
MZZ Stock Price Chart
What is ProShares UltraShort MidCap400's stock price today?
-
The ProShares UltraShort MidCap400 share price today is $9.62
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MZZ is experiencing buying pressure, which is a positive indicator for future bullish movement.
BIS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 44.62 | Sell |
| Chaikin Money Flow: | 1224 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.65 - 15.53) | Sell |
| Bollinger Bands (100): | (14.59 - 16.77) | Sell |
MZZ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 34.69 | Sell |
| Chaikin Money Flow: | 1454 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.75 - 10.51) | Sell |
| Bollinger Bands (100): | (10.22 - 11.48) | Sell |
BIS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.39 | Sell |
| 20-day SMA: | 15.2 | Sell |
| 50-day SMA: | 15.1 | Sell |
| 200-day SMA: | 16.91 | Sell |
| 8-day EMA: | 15.23 | Sell |
| 20-day EMA: | 15.21 | Sell |
| 50-day EMA: | 15.26 | Sell |
| 200-day EMA: | 16.97 | Sell |
MZZ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.85 | Sell |
| 20-day SMA: | 9.97 | Sell |
| 50-day SMA: | 10.52 | Sell |
| 200-day SMA: | 11.36 | Sell |
| 8-day EMA: | 9.8 | Sell |
| 20-day EMA: | 10.02 | Sell |
| 50-day EMA: | 10.37 | Sell |
| 200-day EMA: | 11.57 | Sell |
ProShares UltraShort Nasdaq Biotech Earnings Growth & BIS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares UltraShort MidCap400 Earnings Growth & MZZ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares UltraShort Nasdaq Biotech Technical Analysis
| Oct 2 | Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ProShares UltraShort MidCap400 Technical Analysis
| Oct 2 | Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||